Диссертация (1146691), страница 16
Текст из файла (страница 16)
П. Метаболический синдром/ О. П. Шевченко, Е. А.Праскурничий, А. О. Шевченко.- М.: Издательство Рефарм., 2004.-142с.68.Шишкин, А. Н. Влияние метаболического синдрома на течение ишемической болезни сердца /А. Н. Шишкин, А. С. Дроганова//ВестникСанкт-Петербургского университета. Серия 11. Медицина.- 2014.- Вып.4. С. 19-25.69.Эндокринология: национальное руководство/ под ред. И. И.
Дедова, Г.А. Мельниченко.- М.: ГЭОТАР- Медиа, 2008.- 1072 с.70.Яхонтов, Д. А. Особенности поражения коронарных артерий у больныхишемической болезнью сердца с метаболическими нарушениями приналичии или отсутствии абдоминального ожирения / Д. А. Яхонтов, Н.В. Бухтий, Т. Г. Цибина// Сердце: журнал для практикующих врачей.2010.- Т.
9. № 2.- С. 110-113.71.Abizaid, A. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation / A. Abizaid [et al]// Journal ofthe American College of Cardiology.- 1998.- Vol. 32, № 3.- P. 584-589.72.Alba, A. C. Optimal medical treatment of cardiovascular risk factors: can weprevent the development of heart failure?/ A. C. Alba, D.
H. Delgado// Expert Review of Cardiovascular Therapy.- 2009.- Vol. 7, № 2.- С. 147-157.73.Andreeva-Gateva, P. A. Cluster analysis of the components of the metabolicsyndrome in subjects with an increased risk for diabetes mellitus type 2 / P.A. Andreeva-Gateva [et al.]// Endokrinologya.- 2014.- Vol. 19, № 3.- P.168-185.10174.Andrikopoulos, G. Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome-results from the countrywide target study / G. Andrikopoulos [et al.]// International Journal ofCardiology.- 2013.- Vol.
168, № 2.- P. 922-927.75.Anselmino, M. Glucose lowering treatment in patients with coronary arterydisease is prognostically important not only in established but also in newlydetected diabetes mellitus: a report from the euro heart survey on diabetesand the heart / M. Anselmino [et al.]// European Heart Journal.- 2008.- Vol.29, № 2.- P. 177.76.Aronson, D. Association between fasting glucose and c-reactive protein inmiddle-aged subjects / D. Aronson [et al.]// Diabetic Medicine.- 2004.- Vol.21, № 1.- P.
39-44.77.Azuma. Adipose tissue distribution in relation to insulin resistance in type 2diabetes mellitus/ Azuma [et al.]// Am J Physiol Endocrinol Metab.- 2007.Vol. 293.- P.435-442.78.Barsukov, A. V. Left ventricular hypertrophy as a marker of adverse cardiovascular risk in persons of different age groups/ A. V. Barsukov [et al.]//Advances in Gerontology.- 2015.- Vol. 5, № 2.- P. 99-106.79.Bertoluci, M. C.
Diabetes and cardiovascular disease: from evidence to clinical practice — position statement 2014 of brazilian diabetes society / M. C.Bertoluci [et al.]// Diabetology and Metabolic Syndrome.- 2014.- Vol. 6, №1.- P. 58.80.Bertoncini, G. Coronary risk factors (crf) in acute myocardial infarction(ami) of elderly with and without hypertension/ G. Bertoncini, F. Bertanelli,A. Leone// American Journal of Hypertension.- 1999.- Vol.
12, № 4.- P.197.10281.Bin, H. Impact of metabolic syndrome on clinical outcomes after drugeluting stent implantation in patients with coronary artery disease / H. Bin[et al.]// Angiology.- 2011.- Vol. 62.- P. 440-446.82.Boehm, B. O. The metabolic syndrome/ B. O. Boehm, S. ClaudiBoehm//Scandinavian Journal of Clinical and Laboratory Investigation,Supplement.- 2005.- Vol. 65, № 240.- P.
3-13.83.Bombelli, M. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values / M. Bombelli [et al.]// Journal of Hypertension.- 2009.- Vol. 27, № 12.- P. 24582464.84.Breen, D. M. Effects of insulin on the vasculature /D. M. Breen, А. Giacca//Curr Vasc Pharmacol.- 2011.- Vol. 9.- Р. 321–332.85.Brooks, M. M. Clinical and angiographic risk stratification and differentialimpact on treatment outcomes in the bypass angioplasty revascularizationinvestigation 2 diabetes (bari 2d) trial / M. M. Brooks [et al.]// Circulation.2012.- Vol. 126, № 17.- P. 2115-2124.86.Buettner, H. J. The impact of obesity on mortality in ua/non-st-segment elevation myocardial infarction / H.
J. Buettner [et al.]// European Heart Journal.- 2007.- Vol. 28, № 14.- P. 1694.87.Buettner, H. J. The impact of obesity on mortality in ua/non-st-segment elevation myocardial infarction / H. J. Buettner [et al.]// European Heart Journal.- 2007.- Vol. 28, № 14.- P. 1694.88.Canibus, P. Metabolic syndrome does not increase angiographic restenosisrates after drug-eluting stent implantation/P. Canibus [et al.]// Metabolism.2008.- Vol.57.- Р. 593-597.89.Castelli, W. A population at risk. Prevalence of high cholesterol levels inhyperten- sive patients in the Framingam study/ W. Castelli, K. Anderson//Am.
J. Med.- 1986.- Vol.80.- Р. 23–32.10390.Ceriello, A. Acute hyperglycaemia: a new risk factor during myocardial infarction / A. Ceriello// European Heart Journal.- 2005.- Vol. 26, № 4.- P.328.91.Ceriello, A. Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings / A. Ceriello [et al.] // Diabetes and Vascular DiseaseResearch.- 2008. -Vol. 5.- P. 260-268.92.Chei, C. L. Metabolic Syndrome and the Risk of Ischemic Heart Disease andStroke among Middle-Aged Japanese/ C.L.
Chei [et al.]// Hypertens Res.2008.- Vol. 31.- Р. 1887-1894.93.Ciobotaru, G. Cardiovascular risk factors analysis in patients with suddendeath after acute myocardial infarction / G. Ciobotaru [et al.]// Atherosclerosis.- 2000.- Vol. 151, № 1.- P. 315.94.Cooper, S. Coronary artery disease in people with diabetes: diagnostic andrisk factor evaluation / S. Cooper, J. H. Caldwell// Clinical Diabetes.- 1999.Vol.
17, № 2.- С. 58-70.95.Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials/ M. A. Hlatky [et al.] // Lancet.- 2009.Vol. 373.- P. 1190 — 1197.96.Coronary-artery bypass surgery in patients with left ventricular dysfunction/E. Velazquez [et al.] //N. Engl. J.
Med.- 2011.- Vol. 364.- P. 1607 — 1616.97. Czyzk, A. Clinical course of myocardial infarction among diabetic patients /A. Czyzk [et al.]// Diabetes Care.- 1980.- Vol. 3.- P. 526-529.98.De Caterina, R. Glycaemic control in acute coronary syndromes: prognosticvalue and therapeutic options / R. De Caterina [et al.]//European Heart Journal.- 2010.- Vol. 31, № 13- P. 1557-1564.10499.Deedwania, P.
Hyperglycemia and Acute Coronary Syndrome. A ScientificStatement From the American Heart Association Diabetes Committee of theCouncil on Nutrition, Physical Activity and Metabolism/ P. Deedwania [etal.] //Circulation.- 2008.- Vol. 117.- P. 1610–1619.100.Doehner, W. Impaired Insulin Sensitivity as an Independent Risk Fac-tor for Mortality in Patients With Stable Chronic Heart Failure / W. Doehner[et al.] // J. Am. Coll. Cardiol.-2005.- Vol.
46.- P. 1019-1026.101.Doménech, M. Clinical implications in arterial hypertension and type-2 diabetes mellitus / M. Doménech, A. Coca// Revista Espanola de Cardiologia Suplementos.- 2008.- Vol. 8.- P. 56-62.102.Dutawa, A. Hormonal supplementation in endocrine dysfunction incritically ill patients / A. Dutawa [et al.] // Pharmacological Reports.- 2007.Vol. 59.- P. 139-149.103.Effect of coronary artery bypass graft surgery on survival: overview of10‑ year results from randomised trials by the Coronary Artery Bypass GraftSurgery Trialist Collaboration/ S. Yusuf [et al.] // Lancet.
-1994.- Vol. 344.P. 563 — 570.104.Elezi, S. Diabetes mellitus and the clinical and angiographic outcomeafter coronary stent placement / S. Elezi [et al.]// Journal of the AmericanCollege of Cardiology.- 1998.- Vol. 32, № 7.- P. 1866-1873.105.Epstein, M. Impact of hypertension and other coronary risk factors oncardiovascular disease: implications for coronary artery disease and congestive heart failure — hypertension and diabetes — an evolving paradigm / M.Epstein// American Journal of Hypertension.- 1999.- Vol. 12, № 4.- P.
222.106.Executive Summary of The Third Report of The National CholesterolEducation Program (NCEP) Expert Panel on Detection, Evaluation, andTreatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).JAMA.- 2001.- Vol. 285.- P. 2486-2497.105107.Fang, J. Underestimating medical therapy for coronary disease gain/ J.Fang // N. Engl.
J. Med.- 2011.- Vol. 364.- P. 1671 — 1673.108.Ford, E. S. Prevalence of metabolic syndrome among U.S. adults:Findings from the Third National Health and Nutrition Examination Survey/E. S. Ford, W. H. Giles, W. H. Dietz// JAMA.- 2002.- Vol. 287. P. 356–359.109.Franklin, K. Implications of Diabetes in Patients With Acute CoronarySyndromes. The Global Registry of Acute Coronary Events/ K.
Franklin [etal.]// Arch. Intern. Med.- 2004.- Vol. 164.- P. 1457–1463.110.Gaddam, K. K. Metabolic syndrome and heart failure — the risk, par-adox, and treatment/ K. K. Gaddam, H. O. Ventura, C. J. Lavie// CurrentHypertension Reports.- 2011.- Vol. 13, № 2.- P. 142-148.111.Gehani, A. A. Association of risk factors with acute myocardial in-farction in Middle Eastern countries: the INTERHEART Middle Eaststudy/A. A. Gehani [et al.]// Eur J Prev Cardiol.- 2014.- Vol. 21.- Р. 400410.112.Ghali, J. K.
Influence of left ventricular geometric patterns on prog-nosis in patients with or without coronary artery disease /J. K. Ghali, Y.Liao, R. S. Cooper // J. Am. Coll. Cardiol. -1998. — Vol. 31.- Р. 1635.113.Gheeraert, P. J. Risk factors for primary ventricular fibrillation duringacute myocardial infarction: a systematic review and meta-analysis / P. J.Gheeraert [et al.]// European Heart Journal.- 2006.- Vol. 27, № 21.- P. 2499.114.González-Maqueda, I. Coronary artery disease in diabetics. Diagnosis,prognosis and treatment / I. González-Maqueda// Revista Espanola de Cardiologia Suplementos.- 2007.- Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
